Navigation Links
Breathing Exercises Scores Over Inhalers

A report on asthma and exercises says, for people with mild asthma, shallow breathing through the nose, and some non-specific upper body exercises, will make people to use a reliever inhaler very rarely//.

A medical journal Thorax focuses that breathing techniques are the most commonly used alternative for inhalers. A short-acting beta-2 agonist, such as albuterol, is the reliever used by many people with asthma.

Since these two were 2 different methods (shallow breathing and upper body exercise), but found to give same changes in asthma therapy.

Dr. C. A. Slader, from the University of Sydney, Australia, and his colleagues suggests, less demand on inhalers is not only due to practicing breathing techniques but has significant effect on regularly reinforcing it and feeling relaxed and self-efficant when using beta-2 agonist.

Random assignment of (57 mild asthma) patient to two breathing techniques which was followed for 30 weeks on daily twice basis were made. The outcomes are assessed after 16 weeks by putting subjects to inhale reduced corticosteroids.

Hypoventilation, breath holding after exhalation, and breathing through the nose involves the first technique and the second one (upper body exercise) involved shoulder rotations and arm lifts performed in sync with breathing cycles.

At last about 86 percent reduction and a 50% decrease in the use of beta-2 agonist reliever and inhaled corticosteroids respectively were found. And it was found to have significant effects on quality of life, lung function, or constriction of the airways in response to asthma triggers.


'"/>




Page: 1

Related medicine news :

1. Drug May Make Breathing Easier for Millions
2. Breathing Cancer Causing Compounds During Pregnancy Found To Affect Offspring
3. Fear Of Flying Can Be Overcome By Deep Breathing
4. Sleep Apnea Patients Benefit from Breathing Mask
5. Breathing Exercises A Boon To Asthma Patients
6. Asthma Could be Combated by Breathing Exercises
7. Sensitive Test Developed To Detect Breathing Problems In Very Young Children
8. Prevalence of Self-reported Snoring, Sleep-disordered Breathing in Military
9. Sleep-related Breathing Disorder could Indicate Depression
10. Breathing Exercises help cardiac patients to breeze through surgery
11. Babies with Breathing Troubles at Birth may get Asthma
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting new ... in Lutz, FL. With the help of this highly-effective, yet convenient system, patients ... complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving ... and head shops –can’t help but be heartened by the industry’s current surge. But ... aptly described as “skunk smell.” At last they can simply, safely and effectively ...
(Date:4/25/2017)... ... 2017 , ... Vetoquinol USA® , a world-class developer ... of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. ... level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project ... 2017: Telehealth 2.0 — the American Telemedicine Association’s annual conference, on April 23 in ... for using telemedicine to improve the lives of the poor and underserved in other ...
(Date:4/24/2017)... , ... April 24, 2017 , ... Today, Bright Pink , a national non-profit ... women, names a new CEO. , Bright Pink is proud to announce Katie Thiede ... be moving to a new role as Chairman of the Board and launched a ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Research and Markets has ... and Market Prospects: Addressing Production Complexities Through Risk Management ... ... Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities Through ... assessment of the current trends in the global biosimilars ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
(Date:4/19/2017)... CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate ... the Sheraton Hotel in Toronto, Ontario . ... is scheduled to present on Tuesday, May 2 at 10:00 am. ... the Board, Tony Holler will also attend the event. ... For more details about the ...
Breaking Medicine Technology: